“Exopharm provides continued leadership to the exosome sector.”
Jesus H. That has to be the lamest opening to a Quarterly I’ve ever seen. Just pathetic. If that’s the number one highlight of the quarter I’d say it was stuffed.
- Forums
- ASX - By Stock
- TYP
- Ann: Quarterly Activities Report and Appendix 4C
TYP
tryptamine therapeutics limited
Add to My Watchlist
0.00%
!
3.1¢

Ann: Quarterly Activities Report and Appendix 4C, page-8
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
3.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $43.06M |
Open | High | Low | Value | Volume |
3.2¢ | 3.2¢ | 3.0¢ | $46.85K | 1.542M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 10826 | 3.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.2¢ | 219151 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 86814 | 0.030 |
4 | 230499 | 0.029 |
2 | 125000 | 0.028 |
2 | 110659 | 0.027 |
3 | 260000 | 0.025 |
Price($) | Vol. | No. |
---|---|---|
0.032 | 129782 | 2 |
0.033 | 440000 | 3 |
0.035 | 240540 | 2 |
0.036 | 378900 | 2 |
0.037 | 402415 | 3 |
Last trade - 16.10pm 14/07/2025 (20 minute delay) ? |
Featured News
TYP (ASX) Chart |